NO974150L - 6-arylpyrazolo[3,4-d]pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav - Google Patents
6-arylpyrazolo[3,4-d]pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse deravInfo
- Publication number
- NO974150L NO974150L NO974150A NO974150A NO974150L NO 974150 L NO974150 L NO 974150L NO 974150 A NO974150 A NO 974150A NO 974150 A NO974150 A NO 974150A NO 974150 L NO974150 L NO 974150L
- Authority
- NO
- Norway
- Prior art keywords
- pyrimidin
- ones
- methods
- arylpyrazolo
- preparations
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical class O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40226195A | 1995-03-10 | 1995-03-10 | |
PCT/US1996/003100 WO1996028448A1 (en) | 1995-03-10 | 1996-03-05 | 6-ARYL PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974150D0 NO974150D0 (no) | 1997-09-09 |
NO974150L true NO974150L (no) | 1997-11-07 |
Family
ID=23591191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974150A NO974150L (no) | 1995-03-10 | 1997-09-09 | 6-arylpyrazolo[3,4-d]pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav |
Country Status (13)
Country | Link |
---|---|
US (2) | US5736548A (cs) |
EP (1) | EP0813534A4 (cs) |
JP (1) | JPH11501926A (cs) |
KR (1) | KR19980702892A (cs) |
AU (1) | AU708809B2 (cs) |
CA (1) | CA2211729A1 (cs) |
CZ (1) | CZ280697A3 (cs) |
HU (1) | HUP9801394A3 (cs) |
NO (1) | NO974150L (cs) |
NZ (1) | NZ303886A (cs) |
PL (1) | PL322452A1 (cs) |
WO (1) | WO1996028448A1 (cs) |
ZA (1) | ZA961948B (cs) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6664261B2 (en) | 1996-02-07 | 2003-12-16 | Neurocrine Biosciences, Inc. | Pyrazolopyrimidines as CRF receptor antagonists |
DE19709877A1 (de) | 1997-03-11 | 1998-09-17 | Bayer Ag | 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate |
EA002057B1 (ru) | 1997-04-25 | 2001-12-24 | Пфайзер Инк. | ПИРАЗОЛОПИРИМИДИНОНЫ, КОТОРЫЕ ИНГИБИРУЮТ ЦИКЛИЧЕСКИЙ ГУАНОЗИН-3',5'-МОНОФОСФАТ-ФОСФОДИЭСТЕРАЗУ ТИПА 5 (cGMP PDE5), ДЛЯ ЛЕЧЕНИЯ СЕКСУАЛЬНОГО РАССТРОЙСТВА |
GB9722520D0 (en) | 1997-10-24 | 1997-12-24 | Pfizer Ltd | Compounds |
PT1073658E (pt) * | 1998-04-20 | 2003-12-31 | Pfizer | Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual |
GB9823102D0 (en) | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
GB9823101D0 (en) | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
GB9823103D0 (en) | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
US6225315B1 (en) * | 1998-11-30 | 2001-05-01 | Pfizer Inc | Method of treating nitrate-induced tolerance |
GB9828340D0 (en) * | 1998-12-22 | 1999-02-17 | Novartis Ag | Organic compounds |
KR20020038941A (ko) | 1999-10-11 | 2002-05-24 | 디. 제이. 우드, 스피겔 알렌 제이 | 포스포디에스테라아제 억제제로서의5-(2-치환된-5-헤테로사이클릴설포닐피리드-3-일)-디하이드로피라졸로[4,3-d]피리미딘-7-온 |
TWI265925B (en) | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
IT1318674B1 (it) * | 2000-08-08 | 2003-08-27 | Nicox Sa | Faramaci per l'incontinenza. |
DK1620437T3 (da) | 2003-04-29 | 2009-08-24 | Pfizer Ltd | 5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension |
AU2004274403A1 (en) * | 2003-09-03 | 2005-03-31 | Aventis Pharmaceuticals Inc. | 5-aryl-Pyrazolo(4,3-d)pyrimidines, pyridines, and pyrazines and related compounds |
RU2586333C1 (ru) | 2011-12-09 | 2016-06-10 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные 4-гидрокси-1,2,3,4-тетрагидронафталин-1-ил-мочевины и их применение в лечении, среди прочего, заболеваний дыхательного тракта |
BR112014030410A2 (pt) * | 2012-06-07 | 2017-06-27 | Hoffmann La Roche | inibidores de pirazolopirimidona e pirazolopiridona de tanquirase |
US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
KR102590848B1 (ko) | 2016-12-28 | 2023-10-19 | 다트 뉴로사이언스, 엘엘씨 | Pde2 억제제로서 치환된 피라졸로피리미디논 화합물 |
KR102794907B1 (ko) | 2017-11-27 | 2025-04-14 | 다트 뉴로사이언스, 엘엘씨 | Pde1 억제제로서의 치환된 푸라노피리미딘 화합물 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3165520A (en) * | 1965-01-12 | Certificate of correction | ||
US3211732A (en) * | 1965-10-12 | Pyrazolob:x-d]pyrlil/hdines | ||
GB937722A (en) * | 1960-05-11 | 1963-09-25 | Ciba Ltd | New pyrazolopyrimidines and process for the preparation thereof |
CH398626A (de) * | 1960-05-11 | 1966-03-15 | Ciba Geigy | Verfahren zur Herstellung neuer Pyrazolopyrimidine |
GB1284084A (en) * | 1969-04-17 | 1972-08-02 | Delmar Chem | PROCESS FOR MAKING 1H-PYRAZOLO[3,4-d]PYRIMIDINES |
US3732225A (en) * | 1970-07-23 | 1973-05-08 | Squibb & Sons Inc | Pyrazolo(3,4-d)pyrimidine derivatives |
US4666908A (en) * | 1985-04-05 | 1987-05-19 | Warner-Lambert Company | 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use |
WO1988000192A1 (en) * | 1986-06-26 | 1988-01-14 | Warner-Lambert Company | 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES |
US5075310A (en) * | 1988-07-01 | 1991-12-24 | Smith Kline & French Laboratories, Ltd. | Pyrimidone derivatives as bronchodilators |
GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9121028D0 (en) * | 1991-10-03 | 1991-11-13 | Pfizer Ltd | Therapeutic agents |
US5294612A (en) * | 1992-03-30 | 1994-03-15 | Sterling Winthrop Inc. | 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof |
GB9315017D0 (en) * | 1993-07-20 | 1993-09-01 | Glaxo Lab Sa | Chemical compounds |
-
1996
- 1996-03-05 CZ CZ972806A patent/CZ280697A3/cs unknown
- 1996-03-05 NZ NZ303886A patent/NZ303886A/en unknown
- 1996-03-05 AU AU50933/96A patent/AU708809B2/en not_active Ceased
- 1996-03-05 EP EP96907191A patent/EP0813534A4/en not_active Withdrawn
- 1996-03-05 WO PCT/US1996/003100 patent/WO1996028448A1/en not_active Application Discontinuation
- 1996-03-05 JP JP8527712A patent/JPH11501926A/ja active Pending
- 1996-03-05 KR KR1019970706300A patent/KR19980702892A/ko not_active Withdrawn
- 1996-03-05 HU HU9801394A patent/HUP9801394A3/hu unknown
- 1996-03-05 CA CA002211729A patent/CA2211729A1/en not_active Abandoned
- 1996-03-05 PL PL96322452A patent/PL322452A1/xx unknown
- 1996-03-11 ZA ZA961948A patent/ZA961948B/xx unknown
-
1997
- 1997-01-22 US US08/788,893 patent/US5736548A/en not_active Expired - Fee Related
- 1997-09-09 NO NO974150A patent/NO974150L/no unknown
-
1998
- 1998-01-30 US US09/016,572 patent/US5958929A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5736548A (en) | 1998-04-07 |
WO1996028448A1 (en) | 1996-09-19 |
ZA961948B (en) | 1996-09-17 |
CA2211729A1 (en) | 1996-09-19 |
CZ280697A3 (cs) | 1998-04-15 |
JPH11501926A (ja) | 1999-02-16 |
NO974150D0 (no) | 1997-09-09 |
EP0813534A4 (en) | 1998-06-10 |
EP0813534A1 (en) | 1997-12-29 |
MX9706878A (es) | 1998-06-28 |
HUP9801394A2 (hu) | 1998-10-28 |
AU708809B2 (en) | 1999-08-12 |
NZ303886A (en) | 1998-11-25 |
PL322452A1 (en) | 1998-02-02 |
AU5093396A (en) | 1996-10-02 |
US5958929A (en) | 1999-09-28 |
KR19980702892A (ko) | 1998-08-05 |
HUP9801394A3 (en) | 2000-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974150L (no) | 6-arylpyrazolo[3,4-d]pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav | |
ATE182892T1 (de) | Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren | |
NO984082D0 (no) | Pyrimido£5,4-d|pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremstilling derav | |
NO995006L (no) | Nye forbindelser | |
CA2137203A1 (en) | Protein kinase c inhibitors | |
CA2216535A1 (en) | Protein kinase c inhibitors | |
DK0779888T3 (da) | Pyrimido[5,4-d]pyrimidiner, lægemidler indeholdende disse forbindelser, anvendelse deraf og fremgangsmåder til fremstilling | |
DK0708772T3 (da) | Imidazo[4,5,-c]pyridin-4-aminer | |
NO974151D0 (no) | 6-substituerte pyrazolo (3,4-d) pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav | |
NO954342L (no) | Erytropoietinanalogblandinger, samt fremgangsmåter ved fremstilling derav | |
CA2263561A1 (en) | Thienopyrimidines | |
NO984081D0 (no) | Pyrimido£5,4-d|pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav | |
EP0768312A3 (en) | Bis-Staurosporine and K-252a derivatives | |
CA2072573A1 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
MY118068A (en) | Protein kinase c inhibitor | |
MD1861F2 (en) | Derivatives of the 6-arylpyrido[2,3-d]pyrimidines and naphthyridines, pharmaceutical composition on base thereof, methods of treatment and inhibition of the tyrosine kinaze receptor celle proliferation and migration | |
TR200000197T2 (tr) | Yeni bileşimler | |
MX9800215A (es) | Pirrolopirimidas y procesos para su preparacion. | |
IL118269A0 (en) | Tetralin derivatives pharmaceutical compositions containing the same and processes for the preparation thereof | |
BR9907788A (pt) | Agentes antiinflamatórios seletivos paraglicocorticóides | |
NO993027L (no) | Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler | |
MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
GEP20084346B (en) | Protein kinase c inhibitors | |
FR2713234B1 (fr) | Nouveaux dérivés de la triphénodioxazine, leur préparation et leur utilisation comme pigments. | |
NZ324118A (en) | Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |